Review article: fungal microbiota and digestive diseases
Open Access
- 24 February 2014
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 39 (8) , 751-766
Abstract
Summary: Background: The role of the fungal microbiota in digestive diseases is poorly defined, but is becoming better understood due to advances in metagenomics.Aim: To review the gastrointestinal fungal microbiota and its relationship with digestive diseases.Methods: Search of the literature using PubMed and MEDLINE databases. Subject headings including ‘fungal‐bacterial interactions’, ‘mycotoxins’, ‘immunity to fungi’, ‘fungal infection’, ‘fungal microbiota’, ‘mycobiome’ and ‘digestive diseases’ were used.Results: The fungal microbiota is an integral part of the gastrointestinal microecosystem with up to 106 microorganisms per gram of faeces. Next‐generation sequencing of the fungal 18S rRNA gene has allowed better characterisation of the gastrointestinal mycobiome. Numerous interactions between fungi and bacteria and the complex immune response to gastrointestinal commensal or pathogenic fungi all impact on the pathophysiology of inflammatory bowel disease and other gastrointestinal inflammatory entities such as peptic ulcers. Mycotoxins generated as fungal metabolites contribute to disturbances of gastrointestinal barrier and immune functions and are associated with chronic intestinal inflammatory conditions as well as hepatocellular and oesophagogastric cancer. Systemic and gastrointestinal disease can also lead to secondary fungal infections. Fungal genomic databases and methodologies need to be further developed and will allow a much better understanding of the diversity and function of the mycobiome in gastrointestinal inflammation, tumourigenesis, liver cirrhosis and transplantation, and its alteration as a consequence of antibiotic therapy and chemotherapy.Conclusions: The fungal microbiota and its metabolites impact gastrointestinal function and contribute to the pathogenesis of digestive diseases. Further metagenomic analyses of the gastrointestinal mycobiome in health and disease is needed.Keywords
This publication has 154 references indexed in Scilit:
- Modulation of Intestinal Functions Following Mycotoxin Ingestion: Meta-Analysis of Published Experiments in Animals Toxins, 2013
- Fumonisin B1 and risk of hepatocellular carcinoma in two Chinese cohortsFood and Chemical Toxicology, 2012
- Epidemiology of Invasive Fungal Infections in Latin AmericaCurrent Fungal Infection Reports, 2012
- Importance of Candida–bacterial polymicrobial biofilms in diseaseTrends in Microbiology, 2011
- Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteersThe ISME Journal, 2011
- NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasisInflammatory Bowel Diseases, 2011
- Long-term administration of the fungus toxin, sterigmatocystin, induces intestinal metaplasia and increases the proliferative activity of PCNA, p53, and MDM2 in the gastric mucosa of aged Mongolian gerbilsEnvironmental Health and Preventive Medicine, 2011
- The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental ColitisImmunity, 2010
- Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected womenJournal of Reproductive Immunology, 2008
- A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transitionThe ISME Journal, 2007